Westminster, CA – May 28, 2020 – BioLargo, Inc.
(OTCQB:BLGO), developer of sustainable technologies and a full-service
environmental engineering company, announced that it has been awarded a new US patent
covering its innovative water treatment technology the Advanced Oxidation
System (AOS), designed and manufactured by BioLargo’s subsidiary BioLargo
Water, Inc. The AOS works by generating highly reactive iodine compounds which
destroy water contaminants inside the AOS, while emitting safe, clean water.
Compared to many competing technologies, the AOS costs less to install and
operate, eliminates certain water contaminants existing systems cannot, and
requires less electricity to treat water to enable safe water discharge and/or
reuse.
The new patent – US 10,654,731 B2 – grants broader coverage
(meaning it has fewer specific limitations) of the AOS and its components than
previous patents covering the AOS, thereby providing greater intellectual
property protection to the company as it works to begin commercial trials for
the AOS technology and develops strategic commercial partnerships.
BioLargo Water President Dr. Richard Smith commented, “This patent
was issued at a critical time, as we are hard at work establishing the first
commercial trials for the AOS technology, after which we hope to achieve initial
sales. With broad, secure intellectual property protection, we can launch this
powerful and innovative technology without significant concern about
competitors copying our designs. This is a great day for BioLargo and BioLargo
Water, and we are proud of our team members who made this possible.”
BioLargo
Water currently has a crowdfunding opportunity open. To learn more about this
opportunity to invest in BioLargo Water, go to www.waterworksfund.com.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products
and environmental engineering solutions provider driven by a mission to “make
life better”. We feature unique
disruptive solutions to deliver clean air, clean water and a clean, safe
environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne
Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than masking them,
and is now winning over leading companies in the solid waste handling and
wastewater industries and other industries that contend with malodors and VOCs.
Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System "AOS," a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and
licensor to our subsidiary Clyra Medical (www.clyramedical.com),
which features effective and gentle solutions for chronic infected wounds to
promote infection control and regenerative tissue therapy.
About BioLargo Water
BioLargo Water, Inc. is an Alberta-based Canadian
corporation headquartered at Agri-Food Discovery Place located on campus at the
University of Alberta in Edmonton. BioLargo Water, Inc. developed and is
commercializing the Advanced Oxidation System (AOS), a patented and proprietary
technology aimed at providing cost- and energy-efficient treatment of water and
wastewater to enable practical and affordable safe discharge and reuse of diverse
water sources. Learn more at www.biolargowater.com.
BioLargo Water, Inc. is a subsidiary of BioLargo Water Investment Group, Inc.
(BWIG), which a subsidiary of BioLargo, Inc. (www.biolargo.com),
an innovator of technology-based products and environmental engineering
solutions provider driven by a mission to “make life better”. BioLargo features unique disruptive solutions
to deliver clean air, clean water and a clean, safe environment.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release includes “forward-looking
statements” within the meaning of the safe harbor provisions of the United
States Private Securities Litigation Reform Act of 1995. Actual results may
differ from expectations, estimates and projections and, consequently, you
should not rely on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,”
“anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results
to differ materially from the expected results.
No comments:
Post a Comment